课题基金 / 基金详情

Postdoctoral Training Grant for MDs in Surgical Oncology Research

Postdoctoral Training Grant for MDs in Surgical Oncology Research
肿瘤外科研究医学博士博士后培训补助金
批准号:
8214004
负责人:
David R Jones
金额:
$24.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-20 至 2016-08-31

项目摘要

项目成果

David R Jones的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):考虑到大多数实体肿瘤患者将手术作为其临床治疗的一部分,接受过外科肿瘤学研究培训的医生数量是不够的。改善对这些患者的护理符合NCI的利益。至关重要的是,更多的外科医生参与以患者为中心的研究,其他医生接受与癌症患者手术治疗相关的肿瘤学研究方面的培训。这项申请的三个目标是1)增加训练有素的外科医生进行面向患者的癌症研究的数量,2)增加其他医生在患者中执行与实体肿瘤管理相关的研究的数量,3)增加外科肿瘤学学术实践中的少数族裔和女性外科医生的数量。学员将参加三个研究方向之一:转化实验室科学(TLS)、卫生服务和结果研究(HSO)和肿瘤学临床试验(OCT)。这些课程将是结构化的,并将包括相关的课程和适当的导师。但是,可以灵活地将其他研究领域的培训和其他与研究有关的技能纳入培训,这将增加受训者的教育经验。具有至少两年临床培训的外科住院医师将被允许参加该计划,其他非外科、但与肿瘤相关的MD/DO实习生也可以被录取,但不会超过实习生职位的25%。在任何给定的时间,总共将有四名实习生。学员将进入为期两年的专门培训阶段,其中将包括核心研究项目 与实体肿瘤肿瘤学相关的课程,以及与他们的研究轨迹相匹配的课程。重点将放在结合学术临床实践的研究生涯中生存所需的学习技能上。这些将包括研究伦理、拨款撰写、研究设计、数据分析、预算、手稿写作和压力管理。通过这种方法,将培养一批年轻的、训练有素的外科医生和相关医生,他们将拥有执行专门以人类肿瘤学为中心的高质量、伦理、转化性和临床研究的工具。 公共卫生相关性:只有一小部分外科医生进行研究,旨在通过安全地将科学突破引入癌症患者的护理和管理来改善他们的预后。我们建议培训年轻的外科医生和相关医生,包括那些来自传统上代表性不足的少数民族的医生,以便在他们的职业生涯中进行这项研究,并提高癌症患者的存活率和生活质量。
英文摘要
DESCRIPTION (provided by applicant): The number of physicians trained to perform surgical oncology research is inadequate when considering that most patients with solid tumors undergo surgery as part of their clinical management. Improving the care of these patients is in the interests of the NCI. It is critical that more surgeons are involved in patient-oriented research and that other physicians be trained in oncology research related to the surgical management of cancer patients. The three objectives of this application are 1) To increase the number of well-trained surgeons who perform patient-oriented cancer research, 2) To increase the number of other physicians performing research related to solid tumor management in patients, and 3) To increase the number of minority and female surgeons in the academic practice of surgical oncology. Trainees will be enrolled in one of three research tracks: Translational Laboratory Science (TLS), Health Services and Outcomes research (HSO), and Oncology Clinical Trials (OCT). These tracks will be structured and will include associated curriculum, and appropriate mentors. However, there will be flexibility to include training in other research areas and in othe research- related skills, which will augment the trainees' educational experiences. Surgical residents with a minimum of two years of clinical training will be admitted to the program, and other non-surgical, yet oncologically related MD/DO trainees may be admitted, but will fill no more than 25% of the trainee positions. There will be a total of four trainees at any given time. Trainees will enter a dedicated, two year training period that will include a core research project related to solid tumor oncology, plus coursework selected to match their research track. Strong emphasis will be placed on learning skills required for survival in research careers combined with academic clinical practice. These will include research ethics, grant writing, research design, data analysis, budgeting, manuscript writing, and stress management. By this approach, a cohort of young, well-trained surgeons and associated physicians will be developed who will have the tools to perform high quality, ethical, translational and clinical research specifically centered on human tumor oncology. PUBLIC HEALTH RELEVANCE: Only a small number of surgeons perform research aimed at improving outcomes of cancer patients by safely introducing scientific breakthroughs to their care and management. We propose to train young surgeons and associated physicians, including those from traditionally under-represented minorities, to perform this research throughout their careers and to increase the survival and quality of life of patients suffering fro cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma
Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma
Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
国内基金
海外基金
Research on Quantum Field Theory without a Lagrangian Description
  • 批准号:
    24ZR1403900
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    SATOSHI NAWATA
  • 依托单位:
Cell Research
Cell Research
Cell Research (细胞研究)